UOB Kay Hian

Stay informed with us

By subscribing, you agree to receive research insights and marketing communications from us. You may unsubscribe at any time. See our Privacy Policy for details.

China Healthcare: Bi-Weekly: China's 15th Five-Year Pharma Plan Signals Long-Term Support For Biopharma And AI Drug R&D | Research | UOB Kay Hian Hong Kong